table of content
1 Introduction to Research & Analysis Reports
1.1 Oncology Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Immunotherapy Overall Market Size
2.1 Global Oncology Immunotherapy Market Size: 2022 VS 2030
2.2 Global Oncology Immunotherapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Immunotherapy Players in Global Market
3.2 Top Global Oncology Immunotherapy Companies Ranked by Revenue
3.3 Global Oncology Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Oncology Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Oncology Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Immunotherapy Market Size Markets, 2022 & 2030
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Cytokine-Based Immunotherapy
4.1.4 Cancer Vaccines
4.1.5 CAR-T Cell Therapy
4.1.6 Other
4.2 By Type - Global Oncology Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Oncology Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Oncology Immunotherapy Revenue, 2024-2030
4.2.3 By Type - Global Oncology Immunotherapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Immunotherapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Oncology Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Oncology Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Oncology Immunotherapy Revenue, 2024-2030
5.2.3 By Application - Global Oncology Immunotherapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Oncology Immunotherapy Market Size, 2022 & 2030
6.2 By Region - Global Oncology Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Oncology Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Oncology Immunotherapy Revenue, 2024-2030
6.2.3 By Region - Global Oncology Immunotherapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Oncology Immunotherapy Revenue, 2018-2030
6.3.2 US Oncology Immunotherapy Market Size, 2018-2030
6.3.3 Canada Oncology Immunotherapy Market Size, 2018-2030
6.3.4 Mexico Oncology Immunotherapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Oncology Immunotherapy Revenue, 2018-2030
6.4.2 Germany Oncology Immunotherapy Market Size, 2018-2030
6.4.3 France Oncology Immunotherapy Market Size, 2018-2030
6.4.4 U.K. Oncology Immunotherapy Market Size, 2018-2030
6.4.5 Italy Oncology Immunotherapy Market Size, 2018-2030
6.4.6 Russia Oncology Immunotherapy Market Size, 2018-2030
6.4.7 Nordic Countries Oncology Immunotherapy Market Size, 2018-2030
6.4.8 Benelux Oncology Immunotherapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Oncology Immunotherapy Revenue, 2018-2030
6.5.2 China Oncology Immunotherapy Market Size, 2018-2030
6.5.3 Japan Oncology Immunotherapy Market Size, 2018-2030
6.5.4 South Korea Oncology Immunotherapy Market Size, 2018-2030
6.5.5 Southeast Asia Oncology Immunotherapy Market Size, 2018-2030
6.5.6 India Oncology Immunotherapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Oncology Immunotherapy Revenue, 2018-2030
6.6.2 Brazil Oncology Immunotherapy Market Size, 2018-2030
6.6.3 Argentina Oncology Immunotherapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Immunotherapy Revenue, 2018-2030
6.7.2 Turkey Oncology Immunotherapy Market Size, 2018-2030
6.7.3 Israel Oncology Immunotherapy Market Size, 2018-2030
6.7.4 Saudi Arabia Oncology Immunotherapy Market Size, 2018-2030
6.7.5 UAE Oncology Immunotherapy Market Size, 2018-2030
7 Oncology Immunotherapy Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Oncology Immunotherapy Major Product Offerings
7.1.4 Bristol-Myers Squibb Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Oncology Immunotherapy Major Product Offerings
7.2.4 Merck & Co Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 Roche AG
7.3.1 Roche AG Company Summary
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Oncology Immunotherapy Major Product Offerings
7.3.4 Roche AG Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 Roche AG Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Oncology Immunotherapy Major Product Offerings
7.4.4 AstraZeneca Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Summary
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Oncology Immunotherapy Major Product Offerings
7.5.4 Sanofi S.A. Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Sanofi S.A. Key News & Latest Developments
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Summary
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Major Product Offerings
7.6.4 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 Dendreon Pharmaceuticals Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oncology Immunotherapy Major Product Offerings
7.7.4 Novartis Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Summary
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Oncology Immunotherapy Major Product Offerings
7.8.4 Gilead Sciences Inc. Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Inc. Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Oncology Immunotherapy Major Product Offerings
7.9.4 Merck KGaA Oncology Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Merck KGaA Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
